• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018 年 ASCO/IDSA 成人恶性肿瘤化疗后发热和中性粒细胞减少症门诊管理指南的实用性分析。

Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy.

机构信息

Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 807, Hoguk-ro, Buk-gu, Daegu, Republic of Korea.

Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea.

出版信息

Sci Rep. 2021 Sep 15;11(1):9048. doi: 10.1038/s41598-021-88207-6.

DOI:10.1038/s41598-021-88207-6
PMID:34526516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8443648/
Abstract

Although the clinical practice guideline for outpatient management of febrile neutropenia (FN) in adults treated for malignancy was updated by the ASCO/IDSA in 2018, most patients with FN in our hospital have been hospitalized. We performed this study to analyze the usefulness of the guideline. The medical records of patients hospitalized for FN in Kyungpook National University Chilgok Hospital from May 2016 to April 2018 were retrospectively reviewed. The feasibility of candidates for outpatient management according to the guideline was evaluated based on the outcomes. A total of 114 patients were enrolled and categorized into two groups, low-risk (38.6%) and high-risk (61.4%). The proportion of feasible candidates for outpatient management was 70.2% and was higher in the low-risk than in the high-risk group (90.0% vs. 57.1%; P < 0.001). The low-risk group had no mortality, no resistance to oral amoxicillin/clavulanate or ciprofloxacin, a higher rate of successful empirical antibiotics, and lower rates of glycopeptide or carbapenem administration. A significant number of hospitalized cancer patients treated for FN after chemotherapy were found to be feasible candidates for outpatient management. The guideline can be a useful tool to reduce labor of healthcare workers and hospitalization costs.

摘要

尽管 2018 年 ASCO/IDSA 更新了成人恶性肿瘤患者门诊发热性中性粒细胞减少症(FN)管理的临床实践指南,但我们医院的大多数 FN 患者仍住院治疗。我们进行这项研究是为了分析该指南的实用性。回顾性分析了 2016 年 5 月至 2018 年 4 月在庆北国立大学基尔戈德医院因 FN 住院的患者的病历。根据结局评估了根据指南门诊管理候选者的可行性。共纳入 114 例患者,分为低危(38.6%)和高危(61.4%)两组。门诊管理候选者的可行性比例为 70.2%,低危组高于高危组(90.0%比 57.1%;P<0.001)。低危组无死亡,无口服阿莫西林/克拉维酸或环丙沙星耐药,经验性抗生素治疗成功率更高,糖肽类或碳青霉烯类药物使用率更低。发现化疗后治疗 FN 的大量住院癌症患者是可行的门诊管理候选者。该指南可作为减少医护人员工作量和住院费用的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f1/8443648/5e65592a1958/41598_2021_88207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f1/8443648/5e65592a1958/41598_2021_88207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f1/8443648/5e65592a1958/41598_2021_88207_Fig1_HTML.jpg

相似文献

1
Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy.2018 年 ASCO/IDSA 成人恶性肿瘤化疗后发热和中性粒细胞减少症门诊管理指南的实用性分析。
Sci Rep. 2021 Sep 15;11(1):9048. doi: 10.1038/s41598-021-88207-6.
2
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.成人恶性肿瘤患者发热与中性粒细胞减少的门诊管理:美国临床肿瘤学会与感染病学会临床实践指南更新
J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20.
3
Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.儿童发热性中性粒细胞减少综合征:原发性、持续性和复发性发热的危险因素及预后
J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e962-e971. doi: 10.1097/MPH.0000000000002221.
4
Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review.癌症化疗相关发热性中性粒细胞减少症的门诊管理:风险分层与治疗综述
Am J Health Syst Pharm. 2015 Apr 15;72(8):619-31. doi: 10.2146/ajhp140194.
5
Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.儿童癌症患者中性粒细胞减少性发热的门诊管理的成本效益。
Pediatrics. 2011 Feb;127(2):e279-86. doi: 10.1542/peds.2010-0734. Epub 2011 Jan 10.
6
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.癌症化疗患者中性粒细胞减少性发热的危险因素:系统评价。
Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9. doi: 10.1016/j.critrevonc.2013.12.006. Epub 2013 Dec 12.
7
Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.癌症患儿发热与中性粒细胞减少的管理:澳大利亚和新西兰实践调查
J Paediatr Child Health. 2018 Jul;54(7):761-769. doi: 10.1111/jpc.13899. Epub 2018 Apr 14.
8
Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis.儿童癌症患者发热和中性粒细胞减少症门诊降阶梯管理的经济影响:成本最小化分析。
BMC Health Serv Res. 2024 Aug 24;24(1):981. doi: 10.1186/s12913-024-11442-w.
9
Emergency Department Management of Patients With Febrile Neutropenia: Guideline Concordant or Overly Aggressive?发热性中性粒细胞减少症患者的急诊科管理:符合指南还是过于激进?
Acad Emerg Med. 2017 Jan;24(1):83-91. doi: 10.1111/acem.13079.
10
Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres.对两家新加坡癌症中心实体瘤和淋巴瘤患者化疗后中性粒细胞减少性发热的前瞻性审计。
Ann Acad Med Singap. 2012 Jul;41(7):287-93.

引用本文的文献

1
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study.转移性前列腺癌患者三联疗法与多西他赛疗法的不良事件比较:一项多中心回顾性研究
Prostate Int. 2025 Mar;13(1):41-48. doi: 10.1016/j.prnil.2024.11.003. Epub 2024 Nov 22.
2
Real-World Data to Assess the Proportion of Patients Admitted for Febrile Neutropenia That Could Be Considered at Low Risk: The Experience of the Centre Hospitalier Universitaire de Québec.利用真实世界数据评估可被视为低风险的发热性中性粒细胞减少症住院患者比例:魁北克大学中心医院的经验
Curr Oncol. 2025 Feb 26;32(3):133. doi: 10.3390/curroncol32030133.
3

本文引用的文献

1
Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia.美国急诊科癌症合并发热性中性粒细胞减少症患者近乎普遍住院治疗。
PLoS One. 2019 May 23;14(5):e0216835. doi: 10.1371/journal.pone.0216835. eCollection 2019.
2
Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.对发生低风险发热性中性粒细胞减少事件的癌症患者进行门诊治疗。
Cochrane Database Syst Rev. 2019 Mar 19;3(3):CD009031. doi: 10.1002/14651858.CD009031.pub2.
3
Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia.
识别急性髓系白血病成人患者低风险发热性中性粒细胞减少症入院的预测因素。
Blood Adv. 2024 Dec 24;8(24):6161-6170. doi: 10.1182/bloodadvances.2024014291.
验证临床稳定中性粒细胞减少性发热指数(CISNE)模型在急诊发热中性粒细胞减少症患者中的应用。它能否指导急诊医师做出合理的门诊与住院治疗决策?
PLoS One. 2018 Dec 31;13(12):e0210019. doi: 10.1371/journal.pone.0210019. eCollection 2018.
4
Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA.急诊科癌症发热性中性粒细胞减少症患者预后不良的预测因素:qSOFA的应用价值
J Oncol. 2018 Oct 11;2018:2183179. doi: 10.1155/2018/2183179. eCollection 2018.
5
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.成人恶性肿瘤患者发热与中性粒细胞减少的门诊管理:美国临床肿瘤学会与感染病学会临床实践指南更新
J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20.
6
Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012.2012年美国癌症相关性中性粒细胞减少症或发热住院费用
J Oncol Pract. 2017 Jun;13(6):e552-e561. doi: 10.1200/JOP.2016.019588. Epub 2017 Apr 24.
7
Overcrowding in emergency departments: A review of strategies to decrease future challenges.急诊科过度拥挤:减少未来挑战的策略综述
J Res Med Sci. 2017 Feb 16;22:23. doi: 10.4103/1735-1995.200277. eCollection 2017.
8
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.应用MASCC和CISNE风险分层评分识别急诊科低风险发热性中性粒细胞减少患者。
Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29.
9
Utility of the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index Score as a Criterion for Nonadmission in Febrile Neutropenic Patients with Solid Tumors.癌症支持治疗多国协会(MASCC)风险指数评分作为实体瘤发热性中性粒细胞减少患者不入院标准的效用。
Perm J. 2015 Summer;19(3):37-47. doi: 10.7812/TPP/14-188.
10
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.疑似稳定发热性中性粒细胞减少症患者严重并发症的预测:来自 FINITE 研究前瞻性队列患者的临床稳定发热性中性粒细胞减少症指数的验证。
J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347. Epub 2015 Jan 5.